Like other JAK inhibitors, you are tested for tuberculosis and shingles risk first. Your blood counts and cholesterol are watched while you take it.
Tofacitinib is a JAK inhibitor. It is a tablet that blocks signals inside immune cells that cause inflammation. At the Centre it may be used for inflammatory disease, and for some people with dermatomyositis whose skin or muscle disease has not settled with other medicines. It is used in myositis based on specialist experience, not a formal Canadian myositis approval.
Can help dermatomyositis rashes and muscle disease that other medicines have not settled.
Taken by mouth, with no needles and no fridge.
Useful when first-line medicines have not been enough.
May let your doctor lower your prednisone.
Steady daily dosing keeps inflammation in check.
Your doctor chose this because the likely benefits outweigh the risks for you. Here is the honest, full picture.
Tofacitinib may harm an unborn baby. Do not take it if you are pregnant or trying to become pregnant, and use reliable birth control while on it. Do not breastfeed while taking it. Talk with your doctor before planning a family.
This guide is for learning, not medical advice. Myositis care is different for everyone, and many of these medicines are used based on specialist experience rather than a formal Canadian myositis approval. Never start, stop, or change a medicine without your own doctor. Your doses are decided with your care team at the Centre.